245 related articles for article (PubMed ID: 37935654)
1. Transcriptional reprogramming by mutated IRF4 in lymphoma.
Schleussner N; Cauchy P; Franke V; Giefing M; Fornes O; Vankadari N; Assi SA; Costanza M; Weniger MA; Akalin A; Anagnostopoulos I; Bukur T; Casarotto MG; Damm F; Daumke O; Edginton-White B; Gebhardt JCM; Grau M; Grunwald S; Hansmann ML; Hartmann S; Huber L; Kärgel E; Lusatis S; Noerenberg D; Obier N; Pannicke U; Fischer A; Reisser A; Rosenwald A; Schwarz K; Sundararaj S; Weilemann A; Winkler W; Xu W; Lenz G; Rajewsky K; Wasserman WW; Cockerill PN; Scheidereit C; Siebert R; Küppers R; Grosschedl R; Janz M; Bonifer C; Mathas S
Nat Commun; 2023 Nov; 14(1):6947. PubMed ID: 37935654
[TBL] [Abstract][Full Text] [Related]
2. High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
Kim S; Bagadia P; Anderson DA; Liu TT; Huang X; Theisen DJ; O'Connor KW; Ohara RA; Iwata A; Murphy TL; Murphy KM
Immunity; 2020 Oct; 53(4):759-774.e9. PubMed ID: 32795402
[TBL] [Abstract][Full Text] [Related]
3. Zinc finger-IRF composite elements bound by Ikaros/IRF4 complexes function as gene repression in plasma cell.
Ochiai K; Kondo H; Okamura Y; Shima H; Kurokochi Y; Kimura K; Funayama R; Nagashima T; Nakayama K; Yui K; Kinoshita K; Igarashi K
Blood Adv; 2018 Apr; 2(8):883-894. PubMed ID: 29669755
[TBL] [Abstract][Full Text] [Related]
4. BATF-JUN is critical for IRF4-mediated transcription in T cells.
Li P; Spolski R; Liao W; Wang L; Murphy TL; Murphy KM; Leonard WJ
Nature; 2012 Oct; 490(7421):543-6. PubMed ID: 22992523
[TBL] [Abstract][Full Text] [Related]
5. A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency.
Thouenon R; Chentout L; Moreno-Corona N; Poggi L; Lombardi EP; Hoareau B; Schmitt Y; Lagresle-Peyrou C; Bustamante J; André I; Cavazzana M; Durandy A; Casanova JL; Galicier L; Fadlallah J; Fischer A; Kracker S
J Exp Med; 2023 Jun; 220(6):. PubMed ID: 36917008
[TBL] [Abstract][Full Text] [Related]
6. An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia.
Cherian MA; Olson S; Sundaramoorthi H; Cates K; Cheng X; Harding J; Martens A; Challen GA; Tyagi M; Ratner L; Rauch D
J Biol Chem; 2018 May; 293(18):6844-6858. PubMed ID: 29540473
[TBL] [Abstract][Full Text] [Related]
7. A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency.
; Fornes O; Jia A; Kuehn HS; Min Q; Pannicke U; Schleussner N; Thouenon R; Yu Z; de Los Angeles Astbury M; Biggs CM; Galicchio M; Garcia-Campos JA; Gismondi S; Gonzalez Villarreal G; Hildebrand KJ; Hönig M; Hou J; Moshous D; Pittaluga S; Qian X; Rozmus J; Schulz AS; Staines-Boone AT; Sun B; Sun J; Uwe S; Venegas-Montoya E; Wang W; Wang X; Ying W; Zhai X; Zhou Q; Akalin A; André I; Barth TFE; Baumann B; Brüstle A; Burgio G; Bustamante JC; Casanova JL; Casarotto MG; Cavazzana M; Chentout L; Cockburn IA; Costanza M; Cui C; Daumke O; Del Bel KL; Eibel H; Feng X; Franke V; Gebhardt JCM; Götz A; Grunwald S; Hoareau B; Hughes TR; Jacobsen EM; Janz M; Jolma A; Lagresle-Peyrou C; Lai N; Li Y; Lin S; Lu HY; Lugo-Reyes SO; Meng X; Möller P; Moreno-Corona N; Niemela JE; Novakovsky G; Perez-Caraballo JJ; Picard C; Poggi L; Puig-Lombardi ME; Randall KL; Reisser A; Schmitt Y; Seneviratne S; Sharma M; Stoddard J; Sundararaj S; Sutton H; Tran LQ; Wang Y; Wasserman WW; Wen Z; Winkler W; Xiong E; Yang AWH; Yu M; Zhang L; Zhang H; Zhao Q; Zhen X; Enders A; Kracker S; Martinez-Barricarte R; Mathas S; Rosenzweig SD; Schwarz K; Turvey SE; Wang JY
Sci Immunol; 2023 Jan; 8(79):eade7953. PubMed ID: 36662884
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for the functional roles of the multimorphic T95R mutation of IRF4 causing human autosomal dominant combined immunodeficiency.
Wang G; Feng X; Ding J
Structure; 2023 Nov; 31(11):1441-1451.e3. PubMed ID: 37683642
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4.
Ochiai K; Maienschein-Cline M; Simonetti G; Chen J; Rosenthal R; Brink R; Chong AS; Klein U; Dinner AR; Singh H; Sciammas R
Immunity; 2013 May; 38(5):918-29. PubMed ID: 23684984
[TBL] [Abstract][Full Text] [Related]
10. Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells.
Forero A; Moore PS; Sarkar SN
J Immunol; 2013 Aug; 191(3):1476-85. PubMed ID: 23804715
[TBL] [Abstract][Full Text] [Related]
11. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells.
Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants of the IRF4/DNA homodimeric complex.
Sundararaj S; Seneviratne S; Williams SJ; Enders A; Casarotto MG
Nucleic Acids Res; 2021 Feb; 49(4):2255-2265. PubMed ID: 33533913
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis for the development of adult T-cell leukemia/lymphoma in patients with an IRF4
Sundararaj S; Seneviratne S; Williams SJ; Enders A; Casarotto MG
Protein Sci; 2022 Apr; 31(4):787-796. PubMed ID: 34913532
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression.
Wang L; Toomey NL; Diaz LA; Walker G; Ramos JC; Barber GN; Ning S
J Virol; 2011 Aug; 85(16):8328-37. PubMed ID: 21680528
[TBL] [Abstract][Full Text] [Related]
16. SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity.
Care MA; Cocco M; Laye JP; Barnes N; Huang Y; Wang M; Barrans S; Du M; Jack A; Westhead DR; Doody GM; Tooze RM
Nucleic Acids Res; 2014 Jul; 42(12):7591-610. PubMed ID: 24875472
[TBL] [Abstract][Full Text] [Related]
17. Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma.
Kreher S; Bouhlel MA; Cauchy P; Lamprecht B; Li S; Grau M; Hummel F; Köchert K; Anagnostopoulos I; Jöhrens K; Hummel M; Hiscott J; Wenzel SS; Lenz P; Schneider M; Küppers R; Scheidereit C; Giefing M; Siebert R; Rajewsky K; Lenz G; Cockerill PN; Janz M; Dörken B; Bonifer C; Mathas S
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4513-22. PubMed ID: 25288773
[TBL] [Abstract][Full Text] [Related]
18. An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males.
Do TN; Ucisik-Akkaya E; Davis CF; Morrison BA; Dorak MT
Biochim Biophys Acta; 2010 Feb; 1802(2):292-300. PubMed ID: 19897031
[TBL] [Abstract][Full Text] [Related]
19. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
[TBL] [Abstract][Full Text] [Related]
20. Transcription factors PU.1 and IRF4 regulate activation induced cytidine deaminase in chicken B cells.
Luo H; Tian M
Mol Immunol; 2010 Apr; 47(7-8):1383-95. PubMed ID: 20299102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
